Please ensure Javascript is enabled for purposes of website accessibility Contrarian Fund - Janus Henderson Investors - US Investor
For Individual Investors in the US

Contrarian Fund Holdings

Full Portfolio Holdings

(As of December 31, 2024)

% OF INVESTMENTS
Oracle Corp 5.45
Caesars Entertainment Inc 4.74
Capital One Financial Corp 4.58
Surgery Partners Inc 4.54
PNC Financial Services Group Inc 4.43
Intercontinental Exchange Inc 4.41
Marvell Technology Inc 4.27
Chart Industries Inc 4.11
UnitedHealth Group Inc 4.03
Western Alliance Bancorp 3.89
Amazon.com Inc 3.75
Vertiv Holdings Co 3.70
Taiwan Semiconductor Manufacturing Co Ltd (ADR) 3.22
Dell Technologies Inc 2.98
Sempra 2.89
Argenx SE (ADR) 2.63
Globus Medical Inc 2.43
Howmet Aerospace Inc 2.26
Monster Beverage Corp 2.20
3M Co 2.10
Madrigal Pharmaceuticals Inc 2.04
Teleflex Inc 1.91
Galderma Group AG 1.82
Freeport-McMoRan Inc 1.81
Signet Jewelers Ltd 1.72
Flutter Entertainment PLC 1.70
Core & Main Inc 1.64
Hong Kong Exchanges & Clearing Ltd 1.62
Lantheus Holdings Inc 1.51
Sotera Health Co 1.33
Cullen/Frost Bankers Inc 1.27
Advanced Micro Devices Inc 1.25
Crown Holdings Inc 1.21
Sportradar Group AG 1.08
Vaxcyte Inc 1.06
Constellium SE 0.89
Beauty Health Co, 1.25%, 10/01/26 0.83
Ferguson Enterprises Inc/DE 0.80
HubSpot Inc 0.75
Beauty Health Co 0.34
AST SpaceMobile Inc 0.32
ASTS US 21Feb25 Call (AMERICAN PHYSICAL) BAML OTC 50 0.00
CZR US 17Jan25 Put (AMERICAN PHYSICAL) GS OTC 30 0.00
UNH US 17Jan25 Put (AMERICAN PHYSICAL) CITI OTC 450 0.00
Cash & Equivalents 0.49
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.